| Literature DB >> 32631604 |
Siamak Moghadam-Kia1, Chester V Oddis2, Dana P Ascherman3, Rohit Aggarwal4.
Abstract
The idiopathic inflammatory myopathies, particularly dermatomyositis, are associated with an increased risk of cancer. Lung, ovarian, breast, colon, prostate, and cervical cancers, and hematologic malignancies, are among the most common associated cancers. Risk stratification for cancer in patients with myositis is based on clinical risk factors/red flags, myositis clinical subtypes, and myositis-specific autoantibodies. Clinical risk factors include older age at disease onset, male gender, dysphagia, acute onset/refractory myositis, cutaneous ulceration, necrosis/vasculitis, and elevated inflammatory markers. Appropriate screening strategies are based on the risk level. Further studies are warranted to determine the role of advanced imaging and comprehensive cancer screening.Entities:
Keywords: Cancer screening; Dermatomyositis; Idiopathic inflammatory myopathies
Year: 2020 PMID: 32631604 DOI: 10.1016/j.rdc.2020.05.006
Source DB: PubMed Journal: Rheum Dis Clin North Am ISSN: 0889-857X Impact factor: 2.670